Gal-100

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameGal-100
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGalectin-3 inhibitors
TargetsGalectin-3
Therapy Area/IndicationsInflammationPulmonary FibrosisRespiratory Tract Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGalecto Biotech AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGalecto Biotech AB
Active IndicationsN/A
Inactive IndicationsInflammationPulmonary FibrosisRespiratory Tract Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A